康臣葯業：2021中期報告.pdf

1、Contrast MediumGastroenterology MedicinesKidney Medicines腎科藥物Hepatobiliary Medicines肝膽藥物Orthopedics Medicines骨科藥物Dermatologic Medicines皮膚科藥物對比劑消化系統藥物Women and Children Medicines婦兒藥物 Interim Report 2021 中期報告中期報告Interim Report2021 INTERIM REPORT 2021 中期報告1Corporate Information公司資料2-4Financial Highligh

2、ts財務摘要5Management Discussion and Analysis管理層討論及分析6-16Consolidated Statement of Profit or Loss綜合損益表17Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表18Consolidated Statement of Financial Position綜合財務狀況表19-20Consolidated Statement of Changes in Equity綜合權益變動表21-23Cond

3、ensed Consolidated Cash Flow Statement簡明綜合現金流量表24Notes to the Unaudited Interim Financial Report未經審核中期財務報告附註25-46Review Report審閱報告47-48Other Information其他資料49-64Contents 目錄CONSUN PHARMACEUTICAL GROUP LIMITED 康臣葯業集團有限公司2公司資料Corporate InformationDIRECTORSExecutive DirectorsMr.AN Meng(Chairman)(appoint

4、ed as executive director on 24 March 2021 and appointed as chairman on 9 July 2021)Mr.AN Yubao(Founder,Chairman)(resigned,effective from 9 July 2021)Ms.LI Qian(Founder,Vice Chairlady,Chief Executive Officer)Professor ZHU QuanMr.XU Hanxing(appointed on 24 March 2021)Non-Executive DirectorMs.ZHANG Lih

5、ua(appointed on 9 July 2021)Independent Non-Executive DirectorsMr.SU YuanfuMr.FENG ZhongshiMs.CHEN YujunAUDIT COMMITTEEMs.CHEN Yujun(Chairlady)Mr.FENG ZhongshiMr.SU YuanfuNOMINATION COMMITTEEMr.SU Yuanfu(Chairman)Mr.AN Meng(appointed on 9 July 2021)Ms.CHEN YujunMr.AN Yubao(resigned,effective from 9

6、July 2021)REMUNERATION COMMITTEEMr.FENG Zhongshi(Chairman)Ms.LI QianMr.SU YuanfuCOMPANY SECRETARYMr.YAU Chi Ming(CPA)董事執行董事安猛先生（主席）（於2021年3月24日獲委任為 執行董事，及於2021年7月9日獲委任為主席）安郁寶先生（創始人、主席）（已辭任，自2021年7月9日起生效）黎倩女士（創始人、副主席、首席執行官）朱荃教授徐瀚星先生（於2021年3月24日獲委任）非執行董事張麗華女士（於2021年7月9日獲委任）獨立非執行董事蘇元福先生馮仲實先生陳玉君女士審核委員會陳